4I23:
reference: Insights into the Aberrant Activity of Mutant EGFR Kinase Domain and Drug Recognition., Gajiwala KS, Feng J, Ferre R, Ryan K, Brodsky O, Weinrich S, Kath JC, Stewart A, Structure. 2012 Dec 22. pii: S0969-2126(12)00429-7. doi:, 10.1016/j.str.2012.11.014. PMID: 23273428

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).